Contract Service Directory

Sandoz GmbH





Company Headquarters

Biochemie Str. 10
Kundl, A-6250
Austria

Contract Service Directory

    Related Content

    • Bio News | Biosimilars
      Know the Challenges of Biosimilar Manufacturing

      Know the Challenges of Biosimilar Manufacturing

      Best Practices for a Competitive Market
      Jerry Martin, Pharmaceutical and Life Sciences Consultant to PMMI, and, Dr. Michiel Ultee, Principal, Ulteemit BioConsulting, LLC 04.11.18

    • Clinical Trials | CRO News | Information Technology
      Chiltern Releases Medidata Rave Value Accelerators

      Chiltern Releases Medidata Rave Value Accelerators

      Tools capture, manage and report clinical research data
      06.08.17

    • Breaking News | Drug Delivery | Industry News | Inspections
      Tapemark Passes Regulatory Hurdle

      Tapemark Passes Regulatory Hurdle

      Manufacturing facility completes successful FDA pre-approval and general GMP inspection
      06.07.17


    • Biologics, Proteins, Vaccines
      Trends in New Technologies & Budgets

      Trends in New Technologies & Budgets

      Budget increases in biopharmaceutical industry indicate future growth
      Eric S. Langer, BioPlan Associates 06.06.17

    • Inspections | Regulatory Affairs

      Warning Letters & Close-out Letters

      Why does it take so long to get a close-out letter?
      06.06.17

    • Biologics, Proteins, Vaccines | Biosimilars | cGMP Manufacture
      Biopharmaceutical Contract Manufacturing Market

      Biopharmaceutical Contract Manufacturing Market

      The market continues to grow, projected to exceed $4 billion in 2017
      William Downey, President, HighTech Business Decisions 06.06.17


    • Breaking News | Industry News | Inspections
      BioPharma Services Completes 3 FDA Inspections

      BioPharma Services Completes 3 FDA Inspections

      No Form 483’s reported
      06.05.17

    • Breaking News | Facilities | Industry News | Inspections
      Frontida BioPharm Launches Expansion Efforts

      Frontida BioPharm Launches Expansion Efforts

      Comes on heels of receiving FDA clearance
      05.26.17

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Industry News
      Kemwell Provides Services for U.S. Trial

      Kemwell Provides Services for U.S. Trial

      Supplies biologics drug substance for phase 1 clinical trials for U.S. IND filing
      05.18.17


    • Regulatory Affairs
      The FDA and Metrics

      The FDA and Metrics

      The Agency and industry continue to work together to achieve FDA’s objectives
      David Lonza, Lachman Consultant Services, Inc. 05.09.17

    • Trump Picks New FDA Commish

      Combatting high drug prices and overregulation likely to be high on agenda
      Tim Wright, Editor 04.03.17



    • Capsules | Solid Dosage/Semi-solids

      Generic Drug Trends

      Industry faces tighter capacity, consolidation, and drug pricing uncertainty
      Edward S. Price, President, PCI 03.07.17

    • Aseptic Processing | Bio News | Breaking News | Facilities | Fill/Finish | Industry News | Inspections | Lyophilization

      LSNE Completes Two FDA Inspections

      FDA PAI and general GMP inspection of two aseptic manufacturing plants and QC laboratory completed successfully
      03.06.17

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
      Sanofi and Lonza in $285mn Biologics Pact

      Sanofi and Lonza in $285mn Biologics Pact

      A large-scale facility, to be built in Visp, Switzerland, will be established through a joint venture
      03.06.17

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves

      CrownBio Expands Life Science Division

      Will expand product portfolio; names Debby Saunders executive director
      01.30.17

    • QA/QC | Regulatory Affairs
      FDA’s Quality Agreements Guidance

      FDA’s Quality Agreements Guidance

      Evaluation of FDA’s recently issued Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for Industry
      Paul Mason, Ph.D., Director of Lachman Consultant Services, Inc. 01.26.17

    • cGMP Manufacture | Industry News

      Biofortuna Expands Immunoassay Services

      Invests in production capabilities for immunoassay design, development and manufacture
      01.25.17

    • Ten Tips for Single-Use Tubing Selection

      Ten Tips for Single-Use Tubing Selection

      Download this paper for suggestions on narrowing your choices.